---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-387267"
form_type: "8-K"
ticker: "PSTV"
cik: "0001095981"
company_name: "PLUS THERAPEUTICS, INC."
filed_at: "2026-09-10T12:01:18+00:00"
generated_at: "2026-09-10T12:05:08.117518+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Cerenome secures $21.3M senior secured convertible note facility with 3i Fund

## Summary
- Initial closing expected Sept 10, 2026; gross proceeds $3M; total notes $21,276,596 with 6% OID and 8% interest.
- Notes convertible at $2.74/share, floor $0.50; maturity one year; secured by first-priority lien on assets and CNSide equity.
- Royalty agreement: CNSide pays 2.5% of gross revenues quarterly, capped at 2.5% of outstanding note balance.
- Proceeds for working capital; company forecasts cash runway into 2028; additional tranches up to $15.96M available upon milestones.

## SEC filing metadata
- accession: 0001193125-26-387267
- form_type: 8-K
- ticker: PSTV
- cik: 0001095981
- company_name: PLUS THERAPEUTICS, INC.
- filed_at: 2026-09-10T12:01:18+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1095981/000119312526387267/0001193125-26-387267-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1095981/000119312526387267/d382364d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-387267
- JSON: https://secwatch.observer/filing/0001193125-26-387267.json
- Plain text: https://secwatch.observer/filing/0001193125-26-387267.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.